Back to today’s briefing

Story perspectives

AI-Powered La Jolla Labs Transforms Rare Disease Drug Discovery

2/11/2025

50 6

Summary

Story summary

La Jolla Labs is revolutionizing drug discovery for ultra-rare diseases by harnessing the power of AI and automation. By conducting partner screens without claiming intellectual property, they enrich their AI models with valuable data. With the FDA's new guidance allowing the bypass of large animal models for antisense oligonucleotide therapy, the future of drug design is poised for groundbreaking advancements.

1 of 1

Story summary

La Jolla Labs is revolutionizing drug discovery for ultra-rare diseases by harnessing the power of AI and automation. By conducting partner screens without claiming intellectual property, they enrich their AI models with valuable data. With the FDA's new guidance allowing the bypass of large animal models for antisense oligonucleotide therapy, the future of drug design is poised for groundbreaking advancements.